Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Assets Average (2020 - 2025)

Historic Assets Average for Biodesix (BDSX) over the last 6 years, with Q3 2025 value amounting to $88.2 million.

  • Biodesix's Assets Average fell 1927.04% to $88.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.2 million, marking a year-over-year decrease of 1927.04%. This contributed to the annual value of $98.2 million for FY2024, which is 225.94% up from last year.
  • As of Q3 2025, Biodesix's Assets Average stood at $88.2 million, which was down 1927.04% from $87.0 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Assets Average ranged from a high of $118.3 million in Q1 2021 and a low of $68.4 million during Q2 2022
  • Moreover, its 5-year median value for Assets Average was $88.2 million (2025), whereas its average is $89.6 million.
  • Its Assets Average has fluctuated over the past 5 years, first plummeted by 4176.94% in 2022, then surged by 3295.14% in 2024.
  • Quarter analysis of 5 years shows Biodesix's Assets Average stood at $83.0 million in 2021, then fell by 6.01% to $78.1 million in 2022, then rose by 19.08% to $92.9 million in 2023, then grew by 7.59% to $100.0 million in 2024, then fell by 11.76% to $88.2 million in 2025.
  • Its Assets Average was $88.2 million in Q3 2025, compared to $87.0 million in Q2 2025 and $91.7 million in Q1 2025.